Restricted accessCase reportFirst published online 2011-09
Thoracoscopic Enucleation of Esophageal Gastrointestinal Stromal Tumor Using Prone Positioning in a Patient with Severe Chronic Obstructive Lung Disease
Chronic obstructive lung disease (COPD) is a high-risk factor for pulmonary complications in esophageal surgery. We reported a case of esophageal gastrointestinal stromal tumor (GIST) in a patient with severe COPD. Upper gastrointestinal endoscopy and computed tomography revealed a 3×2-cm submucosal tumor at the lower esophagus, and positron emission tomography showed a hypermetabolic mass (SUVmax=5.6). Forced expiratory volume in 1 second (FEV1) was 33.0% of predicted and FEV1/forced vital capacity ratio was 40.7%. Taking the patient's lung function into account, we performed a thoracoscopic enucleation for the esophageal GIST while the patient was in a prone position. The postoperative course was uneventful and no significant change was observed in the patient's respiratory condition. Performing thoracoscopic surgery on COPD patients in a prone position is a good therapeutic alternative for reducing the occurrence of pulmonary complications.
Get full access to this article
View all access options for this article.
References
1.
MiettinenM, LasotaJ. Gastrointestinal stromal tumors (GISTs): Definition, occurrence, pathology, differential diagnosis and molecular genetics. Pol J Pathol, 2003; 54:3–24.
2.
DeMatteoRP, LewisJJ, LeungD, MudanSS, WoodruffJM, BrennanMF. Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg, 2000; 231:51–58.
3.
GhaferiAA, BirkmeyerJD, DimickJB. Complications, failure to rescue, and mortality with major inpatient surgery in medicare patients. Ann Surg, 2009; 250:1029–1034.
4.
DimickJB, PronovostPJ, CowanJAJr., LipsettPA, StanleyJC, UpchurchGRJr.Variation in postoperative complication rates after high-risk surgery in the United States. Surgery, 2003; 134:534–540; discussion 540–531.
5.
GillinovAM, HeitmillerRF. Strategies to reduce pulmonary complications after transhiatal esophagectomy. Dis Esophagus, 1998; 11:43–47.
6.
JiaoWJ, WangTY, GongM, PanH, LiuYB, LiuZH. Pulmonary complications in patients with chronic obstructive pulmonary disease following transthoracic esophagectomy. World J Gastroenterol, 2006; 12:2505–2509.
7.
InfanteM, AlloisioM, MassonePB, RavasiG. Thoracoscopic resection of an esophageal stromal tumor through the left pleural cavity. Surg Laparosc Endosc Percutan Tech, 2001; 11:273–276.
8.
van der PeetDL, BerendsFJ, Klinkenberg-KnolEC, CuestaMA. Endoscopic treatment of benign esophageal tumors: case report of three patients. Surg Endosc, 2001; 15:1489.
9.
TaniguchiE, KamiikeW, IwaseK, NishidaT, AkashiA, OhashiS, MatsudaH. Thoracoscopic enucleation of a large leiomyoma located on the left side of the esophageal wall. Surg Endosc, 1997; 11:280–282.
10.
YatabeT, KitagawaH, YamashitaK, AkimoriT, HanazakiK, YokoyamaM. Better postoperative oxygenation in thoracoscopic esophagectomy in prone positioning. J Anesth, 2010; 24:803–806.
11.
NishidaT, HirotaS, YanagisawaA, SuginoY, MinamiM, YamamuraY, OtaniY, ShimadaY, TakahashiF, KubotaT. Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version. Int J Clin Oncol Jpn Soc Clin Oncol, 2008; 13:416–430.
12.
BenfieldT, LangeP, VestboJ. COPD stage and risk of hospitalization for infectious disease. Chest, 2008; 134:46–53.
13.
MiettinenM, LasotaJ. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med, 2006; 130:1466–1478.
14.
OtaniY, FurukawaT, YoshidaM, SaikawaY, WadaN, UedaM, KubotaT, MukaiM, KameyamaK, SuginoY, KumaiK, KitajimaM. Operative indications for relatively small (2–5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases. Surgery, 2006; 139:484–492.
15.
DemetriGD, von MehrenM, BlankeCD, Van den AbbeeleAD, EisenbergB, RobertsPJ, HeinrichMC, TuvesonDA, SingerS, JanicekM, FletcherJA, SilvermanSG, SilbermanSL, CapdevilleR, KieseB, PengB, DimitrijevicS, DrukerBJ, CorlessC, FletcherCD, JoensuuH. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med, 2002; 347:472–480.
16.
DemetriGD, van OosteromAT, GarrettCR, BlacksteinME, ShahMH, VerweijJ, McArthurG, JudsonIR, HeinrichMC, MorganJA, DesaiJ, FletcherCD, GeorgeS, BelloCL, HuangX, BaumCM, CasaliPG. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet, 2006; 368:1329–1338.
17.
AvendanoCE, FlumePA, SilvestriGA, KingLB, ReedCE. Pulmonary complications after esophagectomy. Ann Thorac Surg, 2002; 73:922–926.
18.
FergusonMK, DurkinAE. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg, 2002; 123:661–669.
19.
IkeguchiM, MaetaM, KaibaraN. Respiratory function after esophagectomy for patients with esophageal cancer. Hepatogastroenterology, 2002; 49:1284–1286.
20.
AnJY, ChoiMG, NohJH, SohnTS, KangWK, ParkCK, KimS. Gastric GIST: A single institutional retrospective experience with surgical treatment for primary disease. Eur J Surg Oncol, 2007; 33:1030–1035.
21.
CrosbyJA, CattonCN, DavisA, CoutureJ, O'SullivanB, KandelR, SwallowCJ. Malignant gastrointestinal stromal tumors of the small intestine: A review of 50 cases from a prospective database. Ann Surg Oncol, 2001; 8:50–59.
22.
DemetriGD, BenjaminRS, BlankeCD, BlayJY, CasaliP, ChoiH, CorlessCL, Debiec-RychterM, DeMatteoRP, EttingerDS, FisherGA, FletcherCD, GronchiA, HohenbergerP, HughesM, JoensuuH, JudsonI, Le CesneA, MakiRG, MorseM, PappoAS, PistersPW, RautCP, ReichardtP, TylerDS, Van den AbbeeleAD, von MehrenM, WayneJD, ZalcbergJ. NCCN Task Force report: Management of patients with gastrointestinal stromal tumor (GIST)—Update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw, 2007; 5,Suppl 2:S1–S29; quiz S30.
BerrisfordRG, WajedSA, SandersD, RucklidgeMW. Short-term outcomes following total minimally invasive oesophagectomy. Br J Surg, 2008; 95:602–610.
25.
MatthewsBD, WalshRM, KercherKW, SingRF, PrattBL, AnswiniGA, HenifordBT. Laparoscopic vs open resection of gastric stromal tumors. Surg Endosc, 2002; 16:803–807.
26.
KimDJ, HyungWJ, LeeCY, LeeJG, HaamSJ, ParkIK, ChungKY. Thoracoscopic esophagectomy for esophageal cancer: Feasibility and safety of robotic assistance in the prone position. J Thorac Cardiovasc Surg, 2010; 139:53–59.e51.
27.
MiettinenM, Sarlomo-RikalaM, SobinLH, LasotaJ. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol, 2000; 24:211–222.
28.
StelowEB, StanleyMW, MalleryS, LaiR, LinzieBM, BardalesRH. Endoscopic ultrasound-guided fine-needle aspiration findings of gastrointestinal leiomyomas and gastrointestinal stromal tumors. Am J Clin Pathol, 2003; 119:703–708.
29.
Van den AbbeeleAD, BadawiRD. Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs)Eur J Cancer, 2002; 38,Suppl 5:S60–S65.
30.
KamiyamaY, AiharaR, NakabayashiT, MochikiE, AsaoT, KuwanoH, OriuchiN, EndoK. 18F-fluorodeoxyglucose positron emission tomography: Useful technique for predicting malignant potential of gastrointestinal stromal tumors. World J Surg, 2005; 29:1429–1435.
31.
OtomiY, OtsukaH, MoritaN, TerazawaK, FurutaniK, HaradaM, NishitaniH. Relationship between FDG uptake and the pathological risk category in gastrointestinal stromal tumors. J Med Invest, 2010; 57:270–274.
32.
YamadaM, NiwaY, MatsuuraT, MiyaharaR, OhashiA, MaedaO, AndoT, OhmiyaN, ItohA, HirookaY, GotoH. Gastric GIST malignancy evaluated by 18FDG-PET as compared with EUS-FNA and endoscopic biopsy. Scand J Gastroenterol, 2007; 42:633–641.
33.
LeeJR, AnstadtMP, KhwajaS, GreenLK. Gastrointestinal stromal tumor of the posterior mediastinum. Eur J Cardiothorac Surg, 2002; 22:1014–1016.
